COMMUNIQUÉS West-GlobeNewswire

Inovalon Expects Fourth Quarter Revenue Growth of 18% to 20% and Adjusted EBITDA Growth of 78% Assuming the Midpoint, Consistent with Prior Guidance

08/01/2018 - 13:00

Company Issues Preliminary Fourth Quarter and Full Year 2017 Expectations In Conjunction with J.P. Morgan Healthcare Conference Participation Preliminary Fourth Quarter 2017 Expectations Fourth quarter revenue expected [...]

AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue

08/01/2018 - 13:00

Q4 Revenue will be at least $16.5 million, representing 45% growth over prior year 2017 Revenue will be at least $60.0 million, representing 46% growth over prior year ALACHUA, Fla., Jan. 08, 2018 (GLOBE NEWSWIRE) -- [...]

ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology

08/01/2018 - 13:00

LEIDEN, the Netherlands, Jan. 08, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ: PRQR ), today announced that it has entered into a research collaboration agreement with Galapagos N.V. (Euronext & NASDAQ: [...]

Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million, Up 34% Over Prior Year

08/01/2018 - 13:00

DANVERS, Mass. and SAN FRANCISCO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support technologies, today reported preliminary, unaudited, third quarter [...]

Natus Medical Announces 2018 Annual and First Quarter Financial Guidance

08/01/2018 - 12:50

Announces Fourth Quarter preliminary revenue results Announces Fourth Quarter 2017 Financial Results Conference Call Date PLEASANTON, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) [...]

K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2017 Financial Results

08/01/2018 - 12:45

LEESBURG, Va., Jan. 08, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

ChromaDex and Watsons Expand Partnership with TRU NIAGEN™ Retail Launch in Singapore

08/01/2018 - 12:30

IRVINE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), a fully integrated, science-based, nutraceutical company devoted to improving the way people age, announced the launch of TRU NIAGEN ™ [...]

Avivagen Announces Positive Results from Dairy Cattle Trial

08/01/2018 - 12:30

OTTAWA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the use [...]

Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Results

08/01/2018 - 12:30

Preliminary Fourth Quarter Highlights: Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the company’s previous implied guidance range of $345 million to $355 [...]

Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook

08/01/2018 - 12:30

GAITHERSBURG, Md., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced preliminary unaudited 2017 financial results and guidance for 2018. Daniel J. Abdun-Nabi, president and chief [...]

US ARMY Fully Funds Spider Silk Development Contract with Kraig Biocraft Laboratories

08/01/2018 - 12:05

ANN ARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the US ARMY has fully funded its [...]

BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region

08/01/2018 - 12:00

CAMBRIDGE, Mass. and BEIJING, China and SAN DIEGO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301

08/01/2018 - 12:00

PALATINE, Ill., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that topline results from clinical study [...]

Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products

08/01/2018 - 12:00

CINCINNATI, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Enable Injections , Inc., developer of the advanced enFuse™ large volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics, has been awarded the [...]

Dynavax Announces HEPLISAV-B™ is Now Available in the United States for the Prevention of Hepatitis B in Adults

08/01/2018 - 12:00

BERKELEY, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] is now available in the United States [...]

Tecan to present at J.P. Morgan Healthcare Conference

08/01/2018 - 11:01

Männedorf, Switzerland, January 8, 2018 - The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at J.P. Morgan Healthcare Conference on January 11, 2018. The investor presentation by David [...]

Wright Medical Group N.V. Announces Preliminary Fourth Quarter and Full-Year 2017 Net Sales

08/01/2018 - 11:00

Fourth Quarter 2017 Net Sales of Approximately $218 Million Full-Year 2017 Net Sales of Approximately $745 Million At High-End Of Company’s Previously Provided 2017 Guidance Range Company to Present Today at J.P. Morgan [...]

APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi

08/01/2018 - 09:02

VIENNA, Austria and HAMBURG, Germany, Jan. 08, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, and Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) [...]

Saniona AB: Saniona reports top line results from the Tesomet Phase 2a interim study in Prader-Willi syndrome

08/01/2018 - 08:01

PRESS RELEASE January 8, 2018 Saniona, a leading biotech company in the field of ion channels, today announced top line results from its exploratory Phase 2a clinical trial for Tesomet in patients with Prader-Willi [...]